Ardelyx, Inc. (ARDX) Covered Calls

You can sell covered calls on Ardelyx, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ARDX (prices last updated Wed 4:16 PM ET):

Ardelyx, Inc. (ARDX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
6.43 +0.04 6.41 6.43 5.4M - 1.5
Covered Calls For Ardelyx, Inc. (ARDX)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 6.5 0.55 5.88 9.4% 143%
Jun 21 6 0.95 5.48 9.5% 58.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Ardelyx, Inc., a specialized biopharmaceutical company, develops and sells disruptive medicines for the treatment of cardio renal and gastrointestinal diseases in the United States and Asia Pacific. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia; RDX8940, an oral TGR5 agonist; RDX011, a NHE3 inhibitor; and RDX023 program for the development of gut-biased farnesoid X receptor agonists. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.